We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

MeaningCloud Healthcare and Pharmaceutical AI Business to Begin at Konplik Health

MeaningCloud Healthcare and Pharmaceutical AI Business to Begin at Konplik Health content piece image
Credit: Garik Barseghyan/ Pixabay
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

MeaningCloud, today announced the completion of a spin-off from its Artificial Intelligence (AI) businesses into a new, independent company. The spin-off will allow both product and management teams to drive increased responsiveness to customers' particular needs and achieve faster growth through focused and fit-for-purpose operating models.

Konplik Health, Inc. will begin operations immediately with the health-related assets from MeaningCloud, including its leading text analytics, deep semantic analysis, and AI platform, adaptations specific to the life sciences and relevant clients such as Pfizer. Konplik will be dedicated exclusively to the health care, life sciences, and pharmaceutical sectors.

"We're happy to provide the market with a health-focused AI solution," says Jose Gonzalez, CEO of Konplik Health. "Together with our customers, we're leveraging powerful, adaptive intelligence to create solutions that seamlessly integrate data and technology to automate tasks and enable better decisions."

Konplik specializes in Robotic Process Automation and Predictive Analytics that rely on the ability to understand large volumes of textual data. There are many examples from Konplik's 20-years of history in Natural Language Processing and analytics. This history of delivering hundreds of successful AI projects in over 40 different countries to leading innovators in the market includes:

  • Search and evaluation for Drug Discovery expediting development
  • Analysis of Electronic Health Records and Patient Voice for triaging and coding
  • Real-World Evidence analysis of efficacy and safety for Pharmacovigilance
  • Real-time market Intelligence for tendering, shortages, price, and demand forecasting


Innovation is deep in Konplik’s DNA, combined with the growing need for automation and data-driven decision making in the Life Science. The journey to provide unparalleled value to clients, employees, shareholders and society as a whole accelerates today.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.